1YRSBIO-RAY BIOTECH. CO., LTD. PABP BRANCH

Visão geral da empresa

Álbum da empresa3

Informações básicas
With over 35 years of experience in medical research and clinical work, our expertise lies in immunology and oncology. We adhere to the belief of seeking non-harmful remedies and strive to develop natural, safe, and effective healthcare methods. Our outstanding research achievements include inventing DNA vaccines for treating allergic diseases as early as 1996, publishing in the prestigious scientific journal "Nature Medicine," and establishing our reputation as an internationally renowned immunology expert. Throughout years of clinical work, we observed that current treatments for immune-related diseases mostly focus on symptom control without addressing the underlying immune system disorder. These treatments are like "band-aid solutions" that merely provide temporary relief. After dedicated research efforts, we successfully developed the first indigenous anti-allergic probiotic strain in Taiwan. Through rigorous scientific evidence from cell experiments, animal studies, and human trials, our product obtained international patents and certifications as a nationally recognized health food that assists in allergy management. Its success in the market ignited the probiotics trend in Taiwan, and even after more than a decade, its popularity remains strong, propelling the functional probiotics industry in Taiwan forward.
  • Transações
    -
  • Tempo de resposta
    ≤9h
  • Taxa de resposta
    85.71%
Tipo de negócio
Fabricante
País / Região
Taiwan, China
Principais produtosTotal de funcionários
51 - 100 People
Receita anual total
Below US$1 Million
Ano de fundação
2012
Certificações(3)Certificações do produto
-
Patentes
-
Marcas comerciais
-
Principais mercados

A Capacidade do produto

Informações fábrica

Tamanho da fábrica
3,000-5,000 square meters
Localização da fábrica
No. 21-3, Shennong E. Rd., Changzhi Township, Pingtung County 90846, Taiwan (R.O.C.)
Nº das linhas de produção
3
Fabricação de contrato
OEM Service Offered
Valor da produção anual
Above US$100 Million